Kamada (KMDA) Notes Payables (2016 - 2023)
Kamada (KMDA) posted quarterly Notes Payables of $4.4 million for Q2 2023, little changed year-on-year from $4.4 million in Q2 2022, and up 99900.0% on a QoQ basis from $4444.0 in Q1 2023.
Kamada (KMDA) Notes Payables (2016 - 2023) Analysis & Trends
Kamada (KMDA) has reported Notes Payables for 7 consecutive years, with $4.4 million the latest figure, recorded in Q2 2023.
- Quarterly Notes Payables changed 0.11% year-over-year to $4.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.4 million (changed 0.11% YoY) and the FY2022 annual result came in at $4.4 million, up 68.91% from the prior year.
- Notes Payables improved to $4.4 million in Q2 2023 per KMDA's latest filing, from $4444.0 in the prior quarter.
- Over the last five years, Notes Payables for KMDA reached as high as $4.4 million in Q2 2022 and fell as low as $4444.0 in Q3 2022.
- A 5-year average of $1.3 million and a median of $467500.0 in 2019 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2022 — Notes Payables soared 7193.44% — and 2023, when it slumped 99.88%.
- Year by year, Notes Payables stood at $489000.0 in 2019, then slumped by 51.33% to $238000.0 in 2020, then jumped by 1005.46% to $2.6 million in 2021, then jumped by 68.91% to $4.4 million in 2022, then changed by 0.0% to $4.4 million in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $4.4 million, $4444.0, and $4.4 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.44 Mn |
| Mar 31, 2023 | 4,444.00 |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 4,444.00 |
| Jun 30, 2022 | 4.45 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 127,000.00 |
| Dec 31, 2020 | 238,000.00 |
| Sep 30, 2020 | 322,000.00 |
| Jun 30, 2020 | 431,000.00 |
| Mar 31, 2020 | 465,000.00 |
| Dec 31, 2019 | 489,000.00 |
| Sep 30, 2019 | 573,000.00 |
| Jun 30, 2019 | 480,000.00 |
| Mar 31, 2019 | 470,000.00 |
| Sep 30, 2017 | 602,000.00 |
| Jun 30, 2017 | 545,000.00 |